---
id: PHASE-11
title: Integrated Architecture Validation
phase: 11-architecture-validation
status: approved
version: 0.4.0
owners: [independent-reviewer, chief-solution-architect]
depends_on: [PHASE-10, APR-012, APR-013, AI-P11-HANDOFF-001, ASM-024]
last_reviewed: 2026-09-07
approval: APR-013
supersedes: null
---

# Phase 11 — Architecture Validation

## Gate

Gate status: `APPROVED`

Lifecycle: `approved`

Approval: `APR-013` at `2026-09-07T22:19:00+03:30`, including ASM-024
(structure baseline)

Git checkpoint: pending. See
[CHECKPOINT_APR-013.md](CHECKPOINT_APR-013.md).

Phase 12 is authorized for **structure** drafting. Team answers remain
open. `IMPLEMENTATION_AUTHORIZED` remains `false`.

## Purpose

Challenge the complete design as one system, detect contradictions and
gaps, and show that approved requirements can later be implemented and
verified coherently — as **labels and walkthroughs**, not as tests or
code.

## Planned artifacts

- [x] [Independent integrated review](INTEGRATED_REVIEW.md)
- [x] [Requirements and traceability coverage](TRACEABILITY_COVERAGE.md)
- [x] [End-to-End and exceptional-flow walkthroughs](WALKTHROUGHS.md)
- [x] [Cross-domain contradiction and dependency analysis](CROSS_DOMAIN.md)
- [x] [Risk, operability, security, and small-team feasibility](RISK_OPERABILITY.md)
- [x] [Corrective-action and reapproval record](CORRECTIVE_ACTIONS.md)
- [ ] `TEST-*` catalogue / named UAT roster — **not** in this baseline
- [x] [Self-check](SELF_CHECK.md)
- [x] [Independent review](INDEPENDENT_REVIEW.md)
- [x] [Reconciliation](RECONCILIATION.md)
- [x] [Gate checklist](GATE_CHECKLIST.md)
- [x] [Phase 12 handoff](PHASE12_HANDOFF.md)
- [x] [APR-013 checkpoint procedure](CHECKPOINT_APR-013.md)

## Entry criteria

- [x] Phases 01–10 are approved (APR-003 through APR-012).
- [x] Phase 10 Git checkpoint — completed at
  `1d581c4357a784f3170bd42349a47c1b38bde1e6` (CHK-0011).

## How this phase works while answers are still arriving

Walk the approved structure. Mark unanswered policy as
`GUARD_OPEN_POLICY`. Do not invent UOM, names, products, or tests. Do
not write application source. “Ok, Continue” is not approval.

## Exit criteria

- No in-scope Critical/High **structure** contradiction remains **or**
  it is an explicit open extension (ASM-024 accepted).
- Traceability coverage is reported without minting `TEST-*` IDs.
- The user explicitly approved Phase 11 as APR-013.

`IMPLEMENTATION_AUTHORIZED` remains `false`.
